1. Effect of Achyranthes japonica Nakai extract on immunity and anti-inflammation in dogs.
- Author
-
Lee GH, Hwang KA, Kang JH, and Choi KC
- Subjects
- Animals, Anti-Inflammatory Agents chemistry, Cell Line, Cell Survival drug effects, Dogs, Female, Gene Expression Regulation drug effects, Humans, Interleukin-10 genetics, Interleukin-10 metabolism, Lymphocytes physiology, Male, Mice, Nitric Oxide metabolism, Plant Extracts chemistry, Tumor Necrosis Factor-alpha genetics, Tumor Necrosis Factor-alpha metabolism, Achyranthes chemistry, Anti-Inflammatory Agents pharmacology, Interleukin-10 blood, Lymphocytes drug effects, Plant Extracts pharmacology, Tumor Necrosis Factor-alpha blood
- Abstract
Achyranthes japonica Nakai (A. japonica) is a medicinal herb found widely distributed throughout Korea. The biological activities of A. japonica are well-documented and include anti-fungal, anti-inflammatory, and immunity enhancement. The objective of the present study was to investigate the immune-related activities of A. japonica extract in dogs. The extract was acquired by ethanol extraction and purified by filtration. To examine the effect of A. japonica extract on immune cell viability, human lymphocytes, such as Jurkat T-cells and Ramos B-cells, were exposed to the extract. After treatment with the extract, the number of Ramos B-cells was increased, whereas Jurkat T-cells remained unaffected. Griess assay revealed decreased nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated mouse macrophage Raw 264.7 cells after exposure to A. japonica extract. To evaluate the in-vivo effect in dogs, feed containing A. japonica extract was provided to 8 dogs for 2 months. Blood samples were collected before, during, and after consumption of the feed. Peripheral blood mononuclear cells (PBMCs) were isolated from the blood samples and the number of T-cells and B-cells were assessed using flow cytometry with anti-dog fluorescein isothiocyanate (FITC)-conjugated CD3 and anti-dog phycoerythrin (PE)-conjugated CD21 antibodies, respectively. We observed a significant increase in the average number of B-cells in the PBMCs during ingestion of the feed containing A. japonica . In addition, enzyme-linked immunosorbent assay (ELISA) revealed a decrease in the levels of tumor necrosis factor-alpha (TNF-α), a pro-inflammatory cytokine, in 3 out of 8 dogs and increased levels of interleukin-10 (IL-10), an anti-inflammatory cytokine, in 4 out of 8 dogs. Taken together, we believe that these changes indicate that A. japonica extract is beneficial in improving the immunity of dogs by stimulating B-cells and inducing production of anti-inflammatory responses., (Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.)
- Published
- 2020